Federal Register / Vol. 83, No. 166 / Monday, August 27, 2018 / Notices 43693 

address/telephone number listed above 

at least one week prior to the meeting. 

For those unable to attend in person, a 

live webcast will be available. More 

information on registration and 

accessing the webcast can be found at 

http://www.hhs.gov/ash/carb/. 

Members of the public will have the 

opportunity to provide comments prior 

to the Advisory Council meeting by 

emailing CARB@hhs.gov. Public 

comments should be sent in by 

midnight September 19, 2018, and 

should be limited to no more than one 

page. All public comments received 

prior to September 19, 2018, will be 

provided to Advisory Council members; 

comments are limited to two minutes 

per speaker. 

Dated: August 21, 2018. 

Jomana F. Musmar, 

Acting Designated Federal Officer, 

Presidential Advisory Council on Combating 

Antibiotic-Resistant Bacteria Committee 

Manager. 

[FR Doc. 2018–18483 Filed 8–24–18; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI SPORE 

III. 

Date: September 19–20, 2018. 

Time: 5:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Wlodek Lopaczynski, 

M.D., Ph.D., Scientific Review Officer, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W514, Bethesda, MD 20892–9750, 

240–276–6340, lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP 4 for 

Provocative Questions. 

Date: September 21, 2018. 

Time: 7:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Bethesda, MD 20892–9750, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1 for 

Provocative Questions. 

Date: October 4, 2018. 

Time: 7:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Cambria Hotel Rockville, 1 Helen 

Heneghan Way, Rockville, MD 20850. 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240, Bethesda, MD 

20892–9750, 240–276–5122, hasan.siddiqui@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–3 for 

Provocative Questions. 

Date: October 9, 2018. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W234, Bethesda, MD 20892–9750, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Traceback 

Testing: Identification and Genetic 

Counseling of Mutation Carriers (U01). 

Date: October 10, 2018. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W248, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W248, 

Bethesda, MD 20892–9750, 240–276–5007, 

tandlea@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5 for 

Provocative Questions. 

Date: October 18–19, 2018. 

Time: 6:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Byeong-Chel Lee, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W238, Bethesda, MD 20892–9750, 

240–276–7755, byeong-chel.lee@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–1 NCI 

Clinical and Translational R21 and Omnibus 

R03. 

Date: October 25, 2018. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W242, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Zhiqiang Zou, M.D., Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W242, Bethesda, MD 

20892–9750, 240–276–6372, zouzhiq@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI U01 

Review: Integrating Biospecimens into 

Clinical Assay Development. 

Date: November 15, 2018. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W116, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Klaus B. Piontek, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W116, 

Bethesda, MD 20892–9750, 240–276–7849, 

klaus.piontek@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 20, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18399 Filed 8–24–18; 8:45 am] 

BILLING CODE 4140–01–P 


amozie on DSK3GDR082PROD with NOTICES1